Lexicon Pharmaceuticals (LXRX) Gross Profit (2016 - 2026)
Lexicon Pharmaceuticals' Gross Profit came in at $653,000 for Q2 2026, down 97.7% from $28.83 million a year earlier and down 96.9% from the prior quarter.
Powered by 
Analysis
Lexicon Pharmaceuticals (LXRX) Gross Profit (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Lexicon Pharmaceuticals reported Gross Profit of $41.11 million, down 29.1% year-over-year; for FY2025, it came in at $49.53 million, up 62.6% from FY2024.
- Gross Profit carries a five-year compound annual growth rate of 17.6% (FY2020 to FY2025).
- Going back by year, Gross Profit was $30.47 million in FY2024, $1.12 million in FY2023 (+705.0%), $139,000 in FY2022 (-53.4%) and $298,000 in FY2021 (-98.6%).
- The Q2 2026 figure represents the lowest quarterly Gross Profit since Q4 2023.
- Year-over-year, Gross Profit increased in three of the last five quarters, with growth averaging 312.4%.
- The fastest year-over-year change in Gross Profit over five years came in Q3 2024 (growth of 983.2%), and the weakest in Q3 2021 (a decline of 99.6%).
- Business Quant data shows LXRX's Gross Profit at $20.99 million (Q1 2026), $5.29 million (Q4 2025) and $14.17 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Lexicon Pharmaceuticals | 840.12 Mn | 266.67 Mn | 653,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 653,000.00 |
| Mar 31, 2026 | 20.99 Mn |
| Dec 31, 2025 | 5.29 Mn |
| Sep 30, 2025 | 14.17 Mn |
| Jun 30, 2025 | 28.83 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Dec 31, 2024 | 26.21 Mn |
| Sep 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 632,000.00 |
| Sep 30, 2023 | 155,000.00 |
| Jun 30, 2023 | 309,000.00 |
| Mar 31, 2023 | 24,000.00 |
| Dec 31, 2022 | 28,000.00 |
| Sep 30, 2022 | 39,000.00 |
| Jun 30, 2022 | 35,000.00 |
| Dec 31, 2021 | 14,000.00 |
| Sep 30, 2021 | 23,000.00 |
| Jun 30, 2021 | 234,000.00 |
API Access
Lexicon Pharmaceuticals Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=LXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "LXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=LXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();